Details for New Drug Application (NDA): 206105
✉ Email this page to a colleague
NDA 206105 describes POLYETHYLENE GLYCOL 3350, which is a drug marketed by Ani Pharms, Annora Pharma, Aurobindo Pharma Ltd, Breckenridge Pharm, Lgm Pharma, Mylan, Nexgen Pharma Inc, Novel Labs Inc, Nuvo Pharms Inc, Paddock Llc, Ppi-dac, Shree Hari Intl, Strides Pharma, Strides Pharma Intl, and Teva Pharms, and is included in eighteen NDAs. It is available from seventy-two suppliers. Additional details are available on the POLYETHYLENE GLYCOL 3350 profile page.
The generic ingredient in POLYETHYLENE GLYCOL 3350 is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
The generic ingredient in POLYETHYLENE GLYCOL 3350 is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
Summary for 206105
| Tradename: | POLYETHYLENE GLYCOL 3350 |
| Applicant: | Nuvo Pharms Inc |
| Ingredient: | polyethylene glycol 3350 |
| Patents: | 0 |
Pharmacology for NDA: 206105
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Stimulation Large Intestine Fluid/Electrolyte Secretion |
Suppliers and Packaging for NDA: 206105
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 206105 | ANDA | SUNRISE PHARMACEUTICAL, INC | 11534-180 | 11534-180-19 | 119 g in 1 BOTTLE (11534-180-19) |
| POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 206105 | ANDA | SUNRISE PHARMACEUTICAL, INC | 11534-180 | 11534-180-28 | 238 g in 1 BOTTLE (11534-180-28) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | FOR SOLUTION;ORAL | Strength | 17GM/SCOOPFUL | ||||
| Approval Date: | Oct 28, 2016 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
